– UK, London – AstraZeneca PLC (LON: AZN | STO: AZN | Nasdaq: AZN) today announced the appointment of Anna Manz to its Board as a Non-Executive Director effective from 1 September 2023.
She will also join a member of the Audit Committee.
About Anna Manz
Anna Manz is currently an Executive Director and London Stock Exchange Group plc Group CFO.
Anna joined London Stock Exchange Group plc in November 2020 as CFO, ahead of the $27 billion acquisition of Refinitiv. From 2016 – 2020, she was an Executive Director and CFO of Johnson Matthey Plc and led its Finance, Procurement, and IT functions. Before joining Johnson Matthey, Anna spent 17 years at Diageo plc in several senior finance roles, including CSO and as a member of the Executive Committee. She brings extensive expertise in accounting, corporate finance, mergers, and acquisitions, as well as experience in business diversification and transformation.
Anna has been a Non-Executive Director of ITV plc since 2016 and has served on its Audit Committee and Remuneration Committee for most of that period. She will step down as a Non-Executive Director of ITV at the end of August this year.
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Source: https://www.astrazeneca.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
